United States · Wires & real time · Bloomberg

Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

Published by Bloomberg · United States 2 h ago

Genmab A/S shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence…

Read the full article on Bloomberg Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)

Also worth reading

Associated Press (Business)

Baby orangutans in India expose illegal wildlife trade as experts question a billionaire’s zoo

Business Wire

Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026

Dow Jones Newswires

Dragonfly On-demand Webinar: Middle East: Anticipating a convergence of conflicts

MT Newswires

Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial

Share

Also worth reading

Baby orangutans in India expose illegal wildlife trade as experts question a billionaire’s zoo

Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026

Dragonfly On-demand Webinar: Middle East: Anticipating a convergence of conflicts

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows